Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opioid receptors: distinct roles in mood disorders
Pierre‐Eric Lutz, Brigitte L. Kieffer
Trends in Neurosciences (2012) Vol. 36, Iss. 3, pp. 195-206
Open Access | Times Cited: 471

Showing 1-25 of 471 citing articles:

Cross Mark Policy

(2022)
Open Access | Times Cited: 1336
The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
Jiyao Sheng, Liu Shui, Yicun Wang, et al.
Neural Plasticity (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 632
Neonatal Abstinence Syndrome
Prabhakar Kocherlakota
PEDIATRICS (2014) Vol. 134, Iss. 2, pp. e547-e561
Closed Access | Times Cited: 572
Opioid use disorder
John Strang, Nora D. Volkow, Louisa Degenhardt, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 449
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan Williams, Boris D. Heifets, Christine Blasey, et al.
American Journal of Psychiatry (2018) Vol. 175, Iss. 12, pp. 1205-1215
Open Access | Times Cited: 416
The role of 5-HT receptors in depression
Christine N. Yohn, Mark M. Gergues, Benjamin Adam Samuels
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 404
Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement
George F. Koob
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 44-53
Closed Access | Times Cited: 396
Treatment resistant depression: A multi-scale, systems biology approach
Huda Akil, Joshua A. Gordon, René Hen, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 84, pp. 272-288
Open Access | Times Cited: 382
Opioid receptors: drivers to addiction?
Emmanuel Darcq, Brigitte L. Kieffer
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 8, pp. 499-514
Closed Access | Times Cited: 304
Depression, anxiety and acute pain: links and management challenges
Athena Michaelides, Panagiotis Zis
Postgraduate Medicine (2019) Vol. 131, Iss. 7, pp. 438-444
Closed Access | Times Cited: 303
A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks
Eric Erbs, Lauren Faget, Grégory Scherrer, et al.
Brain Structure and Function (2014) Vol. 220, Iss. 2, pp. 677-702
Open Access | Times Cited: 259
Patterns of Kratom use and health impact in the US—Results from an online survey
Oliver Grundmann
Drug and Alcohol Dependence (2017) Vol. 176, pp. 63-70
Closed Access | Times Cited: 257
The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor
Benjamin Adam Samuels, Katherine M. Nautiyal, Andrew C. Kruegel, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 10, pp. 2052-2063
Open Access | Times Cited: 254
Untangling the complexity of opioid receptor function
Rita J. Valentino, Nora D. Volkow
Neuropsychopharmacology (2018) Vol. 43, Iss. 13, pp. 2514-2520
Open Access | Times Cited: 250
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
George F. Koob
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 163-201
Open Access | Times Cited: 233
Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment
Kwan Woo Choi, Yong‐Ku Kim, Hong Jin Jeon
Advances in experimental medicine and biology (2020), pp. 219-235
Closed Access | Times Cited: 213
The Kappa Opioid Receptor: From Addiction to Depression, and Back
Laurence Lalanne, Gülebru Ayrancı, Brigitte L. Kieffer, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 206
Reinforcement learning in depression: A review of computational research
Chong Chen, Taiki Takahashi, Shin Nakagawa, et al.
Neuroscience & Biobehavioral Reviews (2015) Vol. 55, pp. 247-267
Closed Access | Times Cited: 203
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
T. Chase Francis, Mary Kay Lobo
Biological Psychiatry (2016) Vol. 81, Iss. 8, pp. 645-653
Open Access | Times Cited: 202
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone
Journal of Psychopharmacology (2020) Vol. 35, Iss. 2, pp. 109-123
Open Access | Times Cited: 163
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders
Daniel B. Rosoff, George Davey Smith, Falk W. Lohoff
JAMA Psychiatry (2020) Vol. 78, Iss. 2, pp. 151-151
Open Access | Times Cited: 140
Structures of the entire human opioid receptor family
Yue Wang, Youwen Zhuang, Jeffrey F. DiBerto, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 413-427.e17
Open Access | Times Cited: 105
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial
Maurizio Fava, Aslı Memişoğlu, Michael E. Thase, et al.
American Journal of Psychiatry (2016) Vol. 173, Iss. 5, pp. 499-508
Open Access | Times Cited: 163
Evaluation of Opioid Modulation in Major Depressive Disorder
Elliot Ehrich, Ryan Z. Turncliff, Yangchun Du, et al.
Neuropsychopharmacology (2014) Vol. 40, Iss. 6, pp. 1448-1455
Open Access | Times Cited: 156
Targeting multiple opioid receptors – improved analgesics with reduced side effects?
Thomas Günther, Pooja Dasgupta, Anika Mann, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 14, pp. 2857-2868
Open Access | Times Cited: 155
Page 1 - Next Page

Scroll to top